Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, ...

In the first study of its kind, the researchers examined 84 people with temporal lobe epilepsy (epilepsy arising from the temporal lobe at the sides of the head) and hippocampal sclerosis (a condition ...

US regenerative cell therapy specialist Neurona Therapeutics has announced the successful completion of an upsized and ...

A novel study has shed new light on the brain structures critical to human verbal memory, offering valuable insights for ...

The parts of the brain needed to remember words have been identified. Those areas are affected by a common form of epilepsy, say scientists. A team of neurologists and neurosurgeons at University ...

This article is authored by Dr Amit Kumar Agarwal, senior consultant, neurosciences, neurology and stroke medicine, Amrita ...

In the first study of its kind, the researchers examined 84 people with temporal lobe epilepsy (epilepsy arising from the temporal lobe at the sides of the head) and hippocampal sclerosis (a ...